Reading List

The most recent articles from a list of feeds I subscribe to.

OpenAI launches GPT-Rosalind, a specialised AI model for drug discovery and life sciences research


Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering. Access is restricted to a trusted-access programme for vetted enterprise customers including Amgen, Moderna, and Thermo Fisher Scientific. OpenAI has launched GPT-Rosalind, a frontier reasoning model built specifically for life […]



This story continues at The Next Web

Stockholm’s BioLamina secures €20M EIB loan to scale the protein matrices that make cell therapies possible


The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]



This story continues at The Next Web

Physical Intelligence says its new model, π0.7, can direct robots on tasks they weren't trained on, an "early sign" of generalization, surprising researchers (Connie Loizos/TechCrunch)

Connie Loizos / TechCrunch:
Physical Intelligence says its new model, π0.7, can direct robots on tasks they weren't trained on, an “early sign” of generalization, surprising researchers  —  Physical Intelligence, the two-year-old, San Francisco-based robotics startup that has quietly become …

GIC-backed battery maker Envision AESC is considering a $2 billion Hong Kong IPO


The Japan-headquartered EV battery manufacturer, controlled by China’s Envision Group and backed by Singapore’s sovereign wealth fund GIC, is mulling an IPO in Hong Kong that could raise up to $2 billion, Bloomberg reported on Thursday. The move marks a significant change from earlier plans to list in the US. Envision AESC, the electric vehicle […]



This story continues at The Next Web

Sequoia raises $7 billion for its biggest-ever late-stage fund


The Silicon Valley institution has closed roughly $7 billion for its expansion strategy fund, nearly doubling its comparable 2022 vehicle. Alfred Lin and Pat Grady, who took over as co-stewards in November 2025, are making the raise their opening statement on the AI era. Sequoia Capital has raised approximately $7 billion for a new fund, […]



This story continues at The Next Web